Hospital
Pipestone County Medical Center
Pipestone County Medical Center was paid $2.26M by Medicaid between Jan 2018 and Dec 2024, across 61 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 21% of everything it billed.
33Billing provider infoPIPESTONE COUNTY MEDICAL CENTER
PIPESTONE, MN 56164
PIPESTONE, MN 56164
33aNPI1598751240assigned 09/27/2005
33bProvider typeCritical Access Hospital
28Total paid$2.26M
24GClaims71,409
24DCodes billed61
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Minnesota
Rank by total paid#19 of 68
Median peer was paid$798K
This provider vs. median2.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,236 | $152K | |
| 2019 | 10,992 | $339K | |
| 2020 | 6,151 | $215K | |
| 2021 | 8,438 | $326K | |
| 2022 | 11,125 | $435K | |
| 2023 | 12,780 | $468K | |
| 2024incomplete | 9,687 | $329K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 13,439 | 11,877 | $484K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 4,917 | 4,511 | $303K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 13% | 15,361 | 13,669 | $295K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.2% | 1,756 | 1,484 | $186K |
| 80053 | Comprehensive metabolic panel | 6.4% | 2,063 | 1,811 | $144K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.2% | 2,607 | 2,360 | $119K |
| 36415 | Collection of venous blood by venipuncture | 4.6% | 6,592 | 5,671 | $103K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.2% | 5,204 | 4,496 | $72K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.0% | 294 | 250 | $68K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.6% | 4,692 | 3,462 | $59K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 2.4% | 2,862 | 2,797 | $54K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.0% | 331 | 320 | $45K |
49 more codes
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.7% | 732 | $39K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.5% | 983 | $35K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.3% | 433 | $29K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.1% | 608 | $25K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.1% | 597 | $24K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.0% | 460 | $23K |
| 85027 | <1% | 417 | $21K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 313 | $20K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 717 | $18K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,268 | $14K |
| 81001 | <1% | 322 | $12K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 147 | $10K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 126 | $7K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 309 | $6K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 143 | $5K |
| 87070 | <1% | 120 | $5K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 59 | $5K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 87 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 101 | $4K |
| 0240U | <1% | 28 | $3K | |
| 92552 | <1% | 193 | $3K | |
| 80061 | Lipid panel | <1% | 28 | $2K |
| X5622 | <1% | 899 | $2K | |
| 99188 | <1% | 150 | $2K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 749 | $1K |
| 87077 | <1% | 34 | $1K | |
| 84439 | <1% | 29 | $1K | |
| 83735 | <1% | 29 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $1K |
| 82728 | <1% | 14 | $1K | |
| 99173 | <1% | 184 | $985.84 | |
| 90686 | <1% | 460 | $983.82 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 143 | $918.77 |
| 86140 | <1% | 30 | $764.17 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 16 | $755.99 |
| 83550 | <1% | 14 | $674.50 | |
| 83540 | <1% | 14 | $594.76 | |
| J2704 | Injection, propofol, 10 mg | <1% | 17 | $571.32 |
| 87510 | <1% | 18 | $432.88 | |
| 87480 | <1% | 18 | $432.88 | |
| 87660 | <1% | 18 | $432.88 | |
| 87081 | <1% | 15 | $299.12 | |
| 90670 | <1% | 37 | $287.34 | |
| 90656 | <1% | 61 | $284.40 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 58 | $276.69 |
| A9270 | Non-covered item or service | 0% | 40 | $0.00 |
| 90633 | 0% | 15 | $0.00 | |
| 90671 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBURRIS, BRADLEY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Pipestone County Medical Center | Pipestone, MN | $141K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.